Literature DB >> 9209957

Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.

F Wang1, J Larsson, A Abdiu, T Gasslander, P Westermark, T E Adrian, J Permert.   

Abstract

CONCLUSION: The cosecretion of insulin and islet amyloid polypeptide (IAPP) is altered when isolated rat pancreatic islets are incubated in culture media conditioned by human pancreatic cancer cells.
BACKGROUND: Pancreatic cancer is usually associated with impaired glucose tolerance. This study investigates the tumor-derived influence on beta-cell secretion of pancreatic islets.
METHODS: Four conditioned media were prepared from two human pancreatic cancer cell lines (Panc-1 and HPAF), a hamster pancreatic cancer cell line (PC-1), and a fibroblast cell line (Ag1523). Isolated rat pancreatic islets were incubated first in the conditioned media or nonconditioned control medium for 24 h, then in the same kind of media containing 100 microM carbamylcholine for 90 min. Insulin and IAPP secretion were measured by radioimmunoassay.
RESULTS: Islets in media conditioned by Panc-1 and HPAF cells demonstrated dissociation of insulin and IAPP secretion. During 24-h incubation, the dissociation was expressed as selectively decreased insulin secretion. With addition of 100 microM carbamylcholine, the dissociation was expressed as normal secretion of insulin and hypersecretion of IAPP. As a result, the IAPP/insulin molar ratios were increased in both groups during both time periods. The islets in PC-1 and Ag1523 media did not show any significant changes in insulin and IAPP secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209957     DOI: 10.1007/bf02822387

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  37 in total

1.  Relationship between islet amyloid polypeptide (IAPP) deposition and insulin response and beta-cell volume in diabetes mellitus.

Authors:  T Kobayashi; Y Ito; K Nakanish; K Sugawara; M Okubo; T Sugimoto; T Murase; K Kosaka
Journal:  Diabetes Res Clin Pract       Date:  1992-01       Impact factor: 5.602

2.  Stimulation of insulin secretion in vitro by essential aminoacids.

Authors:  R D Milner
Journal:  Lancet       Date:  1969-05-31       Impact factor: 79.321

3.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

4.  Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

Authors:  B Leighton; G J Cooper
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

5.  Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer.

Authors:  J Permert; I Ihse; L Jorfeldt; H von Schenck; H J Arnquist; J Larsson
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

6.  Pancreatic cancer is associated with impaired glucose metabolism.

Authors:  J Permert; I Ihse; L Jorfeldt; H von Schenck; H J Arnqvist; J Larsson
Journal:  Eur J Surg       Date:  1993-02

7.  Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx.

Authors:  J C Henquin; M C Garcia; M Bozem; M P Hermans; M Nenquin
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

8.  Insulin secretion and action in patients with pancreatic cancer.

Authors:  E Cersosimo; P W Pisters; G Pesola; K McDermott; D Bajorunas; M F Brennan
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

9.  Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans.

Authors:  P Westermark; U Engström; G T Westermark; K H Johnson; J Permerth; C Betsholtz
Journal:  Diabetes Res Clin Pract       Date:  1989-09-18       Impact factor: 5.602

10.  Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation.

Authors:  J N Fox; B M Frier; M Armitage; J P Ashby
Journal:  Diabet Med       Date:  1985-03       Impact factor: 4.359

View more
  16 in total

Review 1.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

2.  Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.

Authors:  Katherine Y Fan; Avani S Dholakia; Aaron T Wild; Zheng Su; Amy Hacker-Prietz; Rachit Kumar; Mary Hodgin; Charles C Hsu; Dung T Le; Ana De Jesus-Acosta; Luis A Diaz; Daniel A Laheru; Ralph H Hruban; Elliot K Fishman; Todd D Brown; Timothy M Pawlik; Christopher L Wolfgang; Phuoc T Tran; Joseph M Herman
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

Review 3.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

Review 4.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

5.  Alteration of the Langerhans islets in pancreatic cancer patients.

Authors:  B M Schmied; A B Ulrich; H Matsuzaki; C Li; H Friess; M W Böchler; A Andron-Sandberg; T E Adrian; P M Pour
Journal:  Int J Pancreatol       Date:  2000-12

6.  Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability.

Authors:  Dapeng Zhang; Lihua Cui; Shu Shun Li; Feng Wang
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

Review 7.  The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  J Gastrointest Oncol       Date:  2014-12

8.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

Review 9.  Diabetes and pancreatic cancer.

Authors:  T Muniraj; S T Chari
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

10.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.